These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 32226503)

  • 21. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
    Lin Q; Jiang Y; Zhou F; Zhang Y
    Gene; 2023 Jan; 851():147023. PubMed ID: 36375657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
    BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior
    Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD
    Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of candidate miRNA biomarkers correlated with the prognosis of cell carcinoma and endocervical adenocarcinoma via integrated bioinformatics analysis.
    Zhi S; Jiang B; Yu W; Li Y; Wang H; Zhou T; Li N
    Am J Transl Res; 2022; 14(11):8146-8155. PubMed ID: 36505295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
    Chen D; Guo W; Yu H; Yang J
    Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA database.
    He JY; Li ZM; Chen YT; Zhao BH; Yu C
    Transl Cancer Res; 2024 Apr; 13(4):1721-1736. PubMed ID: 38737688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 28. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
    Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
    Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pain-Related Gene Solute Carrier Family 24 Member 3 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: A Study via Integrated Bioinformatics Analyses and Experimental Verification.
    Zhou S; Jin Q; Yao H; Ying J; Tian L; Jiang X; Yang Y; Jiang X; Gao W; Zhang W; Zhu Y; Cao W
    Comput Math Methods Med; 2023; 2023():4164232. PubMed ID: 36798148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
    Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
    J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
    Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
    [No Abstract]   [Full Text] [Related]  

  • 32. Unveiling the role of HACE1 in cervical cancer: implications for human papillomavirus infection and prognosis.
    Xiang S; Wang M; Li Q; Yang Z
    Transl Cancer Res; 2024 May; 13(5):2175-2186. PubMed ID: 38881936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RILPL2 is associated with the progression and prognosis of cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Dong Y; Wen W; Yuan T; Liu L; Li X
    Am J Transl Res; 2023; 15(2):1072-1084. PubMed ID: 36915776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification.
    Ding X; Wan A; Qi X; Jiang K; Liu Z; Chen B
    Curr Gene Ther; 2024; 24(5):441-452. PubMed ID: 38441026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC00963 May Be Associated with a Poor Prognosis in Patients with Cervical Cancer.
    Chang A; Wang P; Ren J
    Med Sci Monit; 2022 Jul; 28():e935070. PubMed ID: 35818328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis.
    Chen Q; Qiu B; Zeng X; Hu L; Huang D; Chen K; Qiu X
    Cancer Cell Int; 2021 Mar; 21(1):182. PubMed ID: 33766042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer.
    Gou R; Zheng M; Hu Y; Gao L; Wang S; Liu O; Li X; Zhu L; Liu J; Lin B
    BMC Cancer; 2022 Jun; 22(1):690. PubMed ID: 35739489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer.
    Deng Y; Song Z; Huang L; Guo Z; Tong B; Sun M; Zhao J; Zhang H; Zhang Z; Li G
    Aging (Albany NY); 2021 Nov; 13(22):24768-24785. PubMed ID: 34844217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
    Gu X; Li H; Sha L; Mao Y; Shi C; Zhao W
    PeerJ; 2019; 7():e7816. PubMed ID: 31608178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.